NLRP3 and Parkinson disease: In summary, the pathological network during the preclinical phase of PD exhibits characteristics of multi-level, cross-scale interactions, from mitochondrial fragmentation to epigenetic reprogramming of lactylation modifications, from lysosomal collapse to NLRP3 inflammation storms.